Jan-willem W. Henning
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Correction to: A Canadian real‑world, multi‑center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2‑negative advanced breast cancer.
Journal: Breast cancer research and treatment
Published: March 19, 2026
Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada.
Journal: Current oncology (Toronto, Ont.)
Published: July 03, 2025
Retrospective database analysis to assess treatment patterns, clinical outcomes, and healthcare resource utilization in metastatic or recurrent HER2-positive breast cancer in Alberta.
Journal: Cancer treatment and research communications
Published: March 20, 2025
Clinician's guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer.
Journal: Therapeutic advances in medical oncology
Published: November 27, 2024
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: September 28, 2024
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting.
Journal: Current oncology (Toronto, Ont.)
Published: September 20, 2024
A Canadian real-world, multi-center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2-negative advanced breast cancer.
Journal: Breast cancer research and treatment
Published: June 28, 2024
Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada.
Journal: Therapeutic advances in medical oncology
Published: March 22, 2024
Real World Evidence Study to Assess Incidence, Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Early-Stage, High-Risk HER2-Negative Breast Cancer in Alberta, Canada.
Journal: Clinical breast cancer
Published: January 10, 2024
Acceptability, feasibility and preliminary effects of an online group psychotherapy intervention for adolescents and young adults with cancer.
Journal: Psycho-oncology
Published: January 05, 2024
Clinical Considerations for the Integration of Adjuvant Olaparib into Practice for Early Breast Cancer: A Canadian Perspective.
Journal: Current oncology (Toronto, Ont.)
Published: July 13, 2023
Last Updated: 09/26/2026